Facebook Instagram Pinterest Reddit Tumblr X Youtube

Home
About
News
Events
Shop
Directory
Contact Us

Search

Sign in

Welcome! Log into your account

your username

your password

Forgot your password? Get help

Password recovery

Recover your password

your email

A password will be e-mailed to you.

Home
About
News
Events
Shop
Directory
Contact Us

The Psychedelic News Feed: September 2, 2024 – December 29, 2024

By

-

January 30, 2025

12

Previous articlePsychedelic Drug Development Pipeline Updates (Q1’25)

Next article2025’s Psychedelic Policy Surge: A State-by-State, Bill-by-Bill Analysis

RELATED ARTICLES MORE FROM AUTHOR

Field Notes #4: Resilient Refiles, Definium’s Readout, HRSA’s RFI Responses, and J&J’s Neuroplastogen Bet

Weekly Psychedelic Policy Briefing – August 16, 2026

Horizons: Perspectives on Psychedelics

Newsletter

EDITOR PICKS

Field Notes #4: Resilient Refiles, Definium’s Readout, HRSA’s RFI Responses, and...

Weekly Psychedelic Policy Briefing – August 16, 2026

Horizons: Perspectives on Psychedelics

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

FOLLOW US

Facebook Instagram Pinterest Reddit Tumblr X Youtube

©

MORE STORIES

Field Notes #4: Resilient Refiles, Definium’s Readout, HRSA’s RFI Responses, and...